Prior to joining ABio-X, Tracy was Senior Director of Strategy and Business Development at RVAC Medicines, an innovative mRNA company. Previously, Tracy served as Director of Consulting at ChinaBio Group, where she led more than 50 consulting projects assisting US and European companies to develop global and Asia-specific product development, partnership, and commercialization strategies. Tracy received her postdoctoral training at UCLA under Dr. Dale Bredesen and at UCSF under Dr. Frank Longo, and was a recipient of the NIH Shannon Director’s Award and a fellowship from the John Douglas French Alzheimer’s Foundation. Tracy holds a BS from National Taiwan University and a PhD in Biomedical Sciences from Mount Sinai School of Medicine/CUNY.